FindTrial
Sign In

TdT-mediated dUTP nick end labeling assay

GENETIC8 trials

Sponsors

UNC Lineberger Comprehensive Cancer Center, City of Hope Medical Center, Dr. Susan Love Research Foundation, Abramson Cancer Center at Penn Medicine, Mayo Clinic

Conditions

Breast CancerFallopian Tube CancerHead and Neck CancerOvarian CancerPeritoneal Cavity CancerRecurrent Bladder CancerRecurrent MelanomaStage IIIc Melanoma

Early Phase 1

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
CompletedNCT00757549
Mayo ClinicHead and Neck Cancer
Start: 2008-09-30End: 2017-10-25Target: 30Updated: 2017-10-31

Phase 1

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
CompletedNCT00379509
UNC Lineberger Comprehensive Cancer CenterBreast Cancer
Start: 2006-04-30End: 2012-08-31Updated: 2017-03-21
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
CompletedNCT00550784
City of Hope Medical CenterFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
Start: 2001-01-31End: 2014-10-31Updated: 2014-10-07
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors
CompletedNCT00714181
Abramson Cancer Center at Penn MedicineUnspecified Adult Solid Tumor, Protocol Specific
Start: 2008-06-30End: 2013-06-30Updated: 2016-02-18

Phase 2

Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
TerminatedNCT01118351
Case Comprehensive Cancer CenterRecurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder
Start: 2008-10-31End: 2015-09-30Updated: 2019-05-01
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
TerminatedNCT01316692
Vanderbilt-Ingram Cancer CenterRecurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma
Start: 2011-10-31End: 2015-08-31Updated: 2016-05-30

Unknown Phase

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
NCT00671476
Dr. Susan Love Research FoundationBreast Cancer
Start: 2008-02-29Target: 30Updated: 2014-01-10
Study of Proteins in Head and Neck Cancer Cells
CompletedNCT00896948
Vanderbilt University Medical CenterHead and Neck Cancer
Start: 2005-05-31Updated: 2017-03-14

Related Papers

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
2019-06-2432 citations